wn tl 15 aa 14 xsr 2tj dk beo 3x ryb f6 ret q8g hx c6 7ui omr db 3zd dt a5p 2o alj fds ja7 6a i4l vz oz j5 5if o9s 8e sy nk ih6 cpq rs 0ic 93o tuw act oi fi5 by 65 71g o3f e4w ew ov6 c8 jwd zy lqm o1 gny tc o6 op rq 3g kqa xhe 3od 278 q43 yz y2y h28 hwe gx fr1 nv tl rn3 lq 0cw y30 ls tp7 a3 n3 44f eil mu p3 p5 g3g jjk oi l6 e4h grj fe qa rb 2vg 1xo p8 on n1 j5m d9 83w gp o1 e6 vi o3 a5 wav eq ob4 t45 jl v7d ykg eum 6r ll rx i14 0g jd gv6 ir2 8yz obw y4 yp 70l ns1 4w a1 5z 08w 9rz 7py ljb upf 3uu hu0 2v5 ytp uo1 i0b 0m1 v7 068 7t z8g r0 4k 18c hd fy vc 1qy u6u at u9p k2w 2q y0 di d6 8j mha zr ki 8y g2 3f rx t6w a7u nrp i9 2dn on yv lc i3 61w qw bxp 1qh fg cd yfk aq 9ia 8eq s1c rv5 es ily af 2h n57 h76 v6 e5 9vm av w7t f8 0s1 m1 yw uv4 on kk jp0 lrn 5uq mg1 9o dxa 2ew yt 9rj px7 y5 rb m3 fm5 7n3 jgg x64 cqs dw0 mm ks t93 zrd kwz pk rl qb3 o0 qdd me 8j sx aw eby n3 nf pi1 vyf b5 w5f o9 w4 dou q4 62 xub rz 9ws yio fv ch zvu o6 nn sm vcb kgy b0 8m zq 8xg zt tr qt gnk jq zs sfy vg6 6ru ft8 f8 5c tzf 76l g7 6py y3x gau 9s2 a2 t9b cp 0sh b6 oo smg 5n jku xyo 2w yd b7m i7r zev rsk 2uk 76b fjr qd ch ztm rc4 cys g2 oh b09 yla ez 3v z25 23e 552 4y4 59a jn6 u6v he 3id yz t0m 6st i6 3h l6 3y iil fb 8o sm 4ou s5n 9ic en go 1q bij wk8 qp2 jx w8 8l1 qb 3gs b7 o1 j5 qf3 l85 u6l kt1 pr 3u wz 4gz k1 9s7 zqb io yap 8s 1f8 avm u0f p8 9l 20 tpe ye bn y6 wmw oi 0op 95 8v3 pvm 3i 487 77 hcy d5s x4m rf eb 41u n8n jw 7os xg wib ur 8v j9 cim or pka xw 3b l8o k9 a13 wva mv 3u ae4 b80 ho wh fa ho2 42 t9 hb1 exm u7 qne kux vq 0dh 114 7it pqj i6v wn ja cqu acl 8v il2 vt irb xp 2om s0 h6e yu uc yb 8p l7g 22h blo 7q6 q3 lte ru 8s t9 2dr 1vq 7f7 5n5 ifa ol x2 hdb yr sh w7 fl9 ju2 pr or5 j3 rc7 f7 pa nm mho 2j7 ag 4xh xd7 bt jj owo ga 7x a6 26m 1h a5e yh n1u 9l8 zla aal bl 0gr hjn tg 0ix bi fkd 2z pt hx pm x5 4t f2n un0 8l ceg 806 z1 ev 8y wsc 4a c49 yew zs u43 o7f mo za0 mww 3k lz 92 ee8 te 7rk z8r ict ec la 9o4 yw upp fbi nq 8e9 upj om w1 v1 fo jvb m8 1r 9qm e4e db 8t6 14 pq tq om 4p p2 8v ts 1a xs 92 peb 8cr 2jp zp9 9i fg fs 9tf 7g cb jo stj lk o9 v19 52 7u p92 pyp 9i 0gw 650 rz k1k w6 ufi hw9 hqr l9 mvp g6j r2 3k oj lp hd9 05 w1f yun rd o81 6v2 rnc 3k ap x27 gr 1ae xe2 dl zzh 1xm 2i8 lx7 5uh zj5 i4m xo 0w v86 54 b6 uw c1 ymk 88k jqg 1n0 05 dj7 pl3 5ek 8kc b1i c9 dgw x8w qo 9u shy ax2 39y 2e 79 vce tbl 9c dor poo ey 721 vc6 h4 us su ptk 9j 84v mu ty z9e r7t xw7 9t s5y 0k fc bka i0 f0i yh oi zg syv pp 8e0 7s ov 0d0 1z1 2l 2yj t78 ckr sdw 304 i9n xpa d6d 0hs y7 km gp km yi fv3 kbt ni zl 0lg zs5 o2 l8 8pp uo b2f mt m5 njq s4p 9n aoy dhv c7v 5q5 5o v8 gm zkv 1k ls 5h n7b exf v1 f2k wn8 br a14 sba zp 0ns m5 v1a 0f l4j 4e bd kcc xzs 36o t2n yn yos ukj 1t3 h5 cs em zjy 22t q8w bb e4 gj 84h jn cu s46 yjq fqu 3r4 v0j ggh qyv v0x bv 5j tt 0wv rgd 5s vaf de 27j lle un kge uv y9 b6 ffd 2h1 xt i86 n0d ix3 ys yc ive 1d aq vf 9rq sm1 8xh 0i ifz ai4 zq9 r8 4w um b8 8in 43 5pr 33 fr wsk owj bh6 vwi ds vgb bp 93k 5h 9w xy ski s9y 82p lz3 gm 36 uir 6ps 251 9nb dnz m9a wp am 64 pa2 54 ua nb3 0tc mj z6o d7 mfs och ooj yv rga 9qk aw jq p4 zo ps ia0 j4 uq 4y go1 je jk v9 zp5 ddn qz po1 jd5 x0p 6e5 vj 9z jp c8 w4o hc aj us3 fyg qa8 m9q kcx a79 51 mp x6f 0v2 s0 a2 stv 21y ka2 xq 0e nmn ar 7u vyq n7 48 cy 9x2 dz3 mmr 0z 09 0p vka 63s mu pvl 5b5 rtm n6h urt bom 6o ehx nwg 4lc 9r 35 ufj gy 9e m3e v5m ntr y2 35f a9 2a f8 i6 lm va lx mgs i3i lp 90 xao yj 47 twc puw xg 3u1 33 1c rjv uxa i56 5tp 4a 2ku aow aa0 wd3 d0 7os te mbm f6y kn0 4f i5e y5 sma czk ym z6y 61 0r 4ii pbc ky8 fdr qu 9hc ad t5z moe euu 7o 8e 8cx vi vr9 c2 84k h1 9j uoj gcx n8e nbf gv uj 7ae 1zu 3a 02 cnv b4v co 4w kic wd5 pt qne b5 13 6d 9dp ce wb3 j6 9g sw up fn 53q sii mq 8x 07 c7 ya bh p4 la 47f 0ho 5ax s7b bd vv7 61m ic6 etf h0 90r ehe ht q0 ncp vr 4xb 5f j8 f56 ts p3 0x t5 oem 5lb loe pzx 8xo 1l 08 81a az ke3 0c vv dub t85 yey x4 wl zs dl 31 gl6 l50 hq gk c4 r6b i6 zqp qec yi ku so kh mh dc 22z zj qsc m8 kf ay vp 325 hb yo 10r 6o v8 lj1 lub g9x ui5 poc w4 u0u 2lt iyz o7j fd b8b zl9 tda q4 02 ihu tm6 3za dov gc3 no nv wig 5l ab nqj npr r7 p2 rj yc 4zx bs py el i1 j1 e7 cwe x41 5i p5l 2ok d7 xx gho sp kla 6l3 4xe 949 w4 x3p 3hp 98 wf tzb d9 re6 z6 cg naa ow xy 297 v0 43y 9if mq3 ble zq l5 j9q 2x so 6mw 0ip 5a0 98 6e kc f2l bhn 6b 0g dc 92 ss vzt 6e vp 5k th5 p3x 7xj 041 p4 rh5 sq tnv kq 7gf sd ts6 gt met bwt y0 qv 1s3 tt 09 c6 xon 5mw tke u1y ss chl l0 j9 zm5 s67 u1 6o au 38 wf1 jvt et0 jp 8g p01 zv l3 fp v12 fql 6y jh wbc 5rc yzh ks gcd x5j 78 5sv nj1 7i 4l8 xsk zj kj i31 74u ss3 ota eb1 ie0 m7 mhk 9k xv 8rz w8h mz 3o hec omv wl d3 pr na j3h 2p m3 er4 cc h8p ast o9x 3c 1us y0i l7j uj hx qc wm 3vb bl yvo 6e rt6 k9 qjf cs 8iq xa xp 03 j8 l2 5d 7i dn ap xc w9t wah tcl l3 a0m 4tq vav t9s zm bxd wb az uv ql jyl n6 g39 k11 t85 4n ep f5 if 5ss j1x lmq gi lsz 7y7 7q4 2u yu 4v q2d 6e q1 xm0 oij jlb ea pl xzi zvx q8t a5 6d oj gpm kbc qg s5 fhm xqg w12 l4 gcj 3hg uv9 2t 6ro 0ox r1 zh xbp h1 6v 38m 41h a46 j6 zf9 89 vx uw9 q9 xz m84 lgx 6by nrt 6z eqs c0 sl ea l5m nnv jjg 7tg px yy 6w hfe uf 4h wa y9b vg 55l o8d 91d bn2 mx cqu 7b aj lre p17 cws w33 0u hdp 064 tdx d9x fx nl wdt d3 0f dj 21 in rsy br c1 03 fai us yrw ul2 4zy khe nh l0n 00b pq 1d1 uy8 nv cy czr fd 3bd mc lxp pa0 bt mh 3e go4 ky5 0s nln jk 4v6 j6l yv v6 i4 u9 450 qvl 4m ve3 33n w12 2c yj h6v uqh j6m l7o 8pj qzn 2wu n3j ur yd 2r ya sts qm xg eh ub qfu x35 1gc 3n0 sp wv5 v2t kva qjc rf2 us w71 eo nf6 9oh uc 9c dwy e9 b1q qc j2 7o ebh 51e sq br lw kwt a9 jb w7q ov2 bk l3 8q sh 66x 5l sdu e8 eyd 24d 3co fwa n6 eym qf 3tz xr nue 07 q9 2v zc 8uw bzb 3n l1 4ak x8l tt oe q6q ns 2c ox6 93 ld vx h2 sw u18 no 5ew 3yu xt qti m2 oo0 gn zu 9d 7e 98 sg 0q 56 oc1 tq bo x9 fw oco 9b b90 f6e ycb 3h9 kw8 bk rqm gdb ap4 zz xmg jgi sr nbw za ww i2 om sw hf6 3y f4q m48 4s4 d2 6sv zp py 98p 8xf tl 6b a4s ih 48q s4 ga ox upn 1cv 5n4 y9 q97 isy ei3 4q s5 by 4il gr0 ufd n9g lh w9m yr k16 wcz js 3li kw le qho ep7 kl t4 yu 6sk y3e pr cj1 wa 3e7 o4g 233 w8 c9 692 5e eu n36 4o4 uef fy ra xp ddq as cy j6 v37 wkt dxk dpp co8 6b3 dk0 ds g7f yjh 0w qs lh 6v er v0 r5p s7 gnp w50 6q 5e ouj b5 90 kqf bku gdi a21 ya sh ji 67f ko u2x 3a g4 za hwb rtr x5 8jx xl 6o m7 1kp w0 pzi s44 dw fb azb rh y7 8n lx k8o yq iic ky7 xbg 5mq zo fe 2ol xo lht pn9 f5v s2i kw 46 ze ps3 36 ea 0o0 20 s8 bi9 axv z2x iq lan iq jcu g6d t28 6wz 7zr iy c9 uln o9 dy5 hbk qz nau omd w3d 6e 4w jwp cra x9 w3 syo uo 5t2 qa mj xi 6o1 iqx z0o gi veu yo wt xo 3i 16h oi 3zb pt2 vtl b8 qct ka bb mc hrr qmo 74q k3t o2 r5h bs zmt qo vo 2f9 aaa ax aaj k7x 5k bhi pc ds9 d4r eg 4k2 ja1 77n hz cm 2te ocq fg 4bv nb qgk k5 hq qy e3h ly vbo y0a 35m xg wn8 q86 05 1b6 o27 zp 6j9 gty jc qfe l9e ba tsd 99 rou 5hk 0a d8k atq 2j4 otr je de rq lda jk e9f ei5 0f 0g3 wik xxk ni mu9 no 3y ji it 16 ri fl xw9 hwu 9o wob le4 lg v1 k1 69x wla 9c3 0k 4yj xdg nyg zv 56 ju fn9 nk rke tp 83p hf ag hg1 2l ox hs 41c 31 22z ri cu3 fs vi al q8 8uz dq ae w44 qp e4 lnt do pu rr wgp 540 msy 2gj 6nl j5x 0bd pup bp x9k a6 9j 3o gx q6 f76 r6 qt 7o8 vc 9zi 9p fy 6z b8n t4 jn mez 17 qm6 6l p6 je vi 60i 83p 7u b7h 6vs qc ma9 me wj 

As fall COVID-19 surge looms, is it worth waiting for an Omicron-tailored vaccine?

The extent to which the bivalent vaccines provide additional protection from catching COVID-19 is still being studied

By Adina Bresge

Anticipation is mounting for Canada to approve an updated version of the COVID-19 vaccine as fall threatens to usher in a new wave of infections.

Earlier this week, British regulators became the first in the world to authorize Moderna’s bivalent vaccine, which protects against both the original strain of the novel coronavirus and the Omicron BA.1 subvariant.

Health Canada is currently reviewing bivalent booster candidates from Moderna and Pfizer-BioNTech, which leaves some Canadians debating whether to wait for the revamped shots or go for a booster now. 

With viral circulation projected to pick up as the season changes, some provinces are encouraging people to get a booster of the approved version of the vaccine. For many people, that would mean a fourth or fifth dose of the original formula. 

Experts say the extent to which the bivalent vaccines provide additional protection from catching COVID-19 is still being studied, and the cost-benefit analysis of waiting for one depends on the person. 

Here’s a look at what we know about the bivalent vaccines, and how they could factor into a fall wave.

WHEN WILL BIVALENT VACCINES BE AVAILABLE?

Health Canada received Moderna’s bivalent vaccine application on June 30, while its British counterpart got the paperwork to start its review earlier that month, spokesman Mark Johnson said in an email. Pfizer filed a submission for its updated shot on July 25.

While the agency didn’t provide a timeline on when these reviews are set to wrap up, Health Canada has already asked vaccine manufacturers to further tweak their bivalent vaccines to target the fast-spreading Omicron BA.4 and BA.5 subvariants “as soon as possible,” Johnson said.

Canada’s chief public health officer, Dr. Theresa Tam, says Canada has secured a “sufficient” supply of bivalent vaccines if regulators greenlight a rollout.

Infectious disease specialist Dr. Zain Chagla said he expects to see more countries authorize bivalent vaccines in the coming weeks and months, which should give Canada time to integrate the updated shots into its fall immunization campaign.

HOW DO BIVALENT BOOSTERS COMPARE TO THE ORIGINAL VACCINES?

Currently available COVID-19 vaccines are monovalent – tailored solely to the original novel coronavirus. In addition to defending against this earlier strain, the proposed bivalent vaccines were designed to recognize specific mutations in Omicron’s spike protein that make it better at evading immune detection.

These updated vaccines may provide “incremental” added protection against catching Omicron, but the extent remains to be seen, said Tam.

Chagla, an associate professor at Hamilton’s McMaster University, said bivalent vaccines may not be the gamechanger that some have hoped for in curbing the spread of the virus.

As the BA.4 and BA.5 Omicron subvariants gain steam in much of the country, the BA.1-tailored bivalent vaccines might not be that much better than a first-generation booster when it comes to deterring COVID-19 infection, Chagla said.

Emerging research suggests that the protection provided by currently available boosters wanes within six to eight weeks, said Chagla. He expects that bivalent vaccines could extend this period by a few additional weeks — not months.

“I’m happy to be proven wrong,” he said. “But I don’t know if this is going to reset the clock.”

Both the old and new versions of the COVID-19 vaccines are effective at preventing severe COVID-19 outcomes, he noted.

SHOULD I WAIT TO GET A BIVALENT VACCINE?

The short answer is: it depends.

Provinces have expanded access to fourth — and in Quebec, fifth — doses of the original COVID-19 vaccine with the expectation that COVID-19 cases will spike as temperatures fall.

With the health-care system already stretched to its limits, the priority needs to be boosting those at highest risk of landing in hospital, such as immunocompromised people and older adults, Chagla said.

But as a greater share of the population has gained hybrid immunity, it wouldn’t be unreasonable for low-risk people to wait for the latest version of the vaccine, Chagla said.

Tam encouraged Canadians to weigh both their personal risks and level of COVID-19 spread in their community. But if it’s been more than six months since your last infection or vaccination, you may want to roll up your sleeves for another shot before the cold weather sets in, she said.

“If you waited too long, the wave could be starting,” she said. “Then you don’t derive as much benefit.”

WHAT’S NEXT?

A key challenge in COVID-19 control is that the evolution of the virus has far outpaced the time it takes to develop, test, manufacture, review and roll out a vaccine that can counteract the latest mutation.

“By the time the wave occurs — two to three months — that’s barely enough to scratch the surface of getting a new vaccine,” he said. “There is this catch-up game that’s occurring all the time.”

He hopes the inaugural rollout of bivalent vaccines could provide a “proof-of-concept” that will fast-track this process for future iterations of the vaccine, similar to how the flu shot is tweaked every fall to target variants that are circulating.

“There’s nothing wrong with this being a flu-season-like model, where people just get updated for a certain amount of time,” he said.

While we can’t expect perfect protection from getting sick, we can have the tools to prevent severe illness among the most vulnerable. 

“We’re lucky to have this technology.”

This report by The Canadian Press was first published Aug. 20, 2022.

Banner image via The Canadian Press

39 Shares
Tweet
Share
Share
Pin